BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study
Conditions: Hurler Syndrome; Inherited Metabolic Disorder; Lysosomal Storage Disorder; Metachromatic Leukodystrophy; Inborn Errors of Metabolism Interventions: Biological: rivogenlecleucel; Drug: rimiducid Sponsor: Bellicum Pharmaceuticals Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Leukodystrophies | Pediatrics | Stem Cell Therapy | Stem Cells | Study | Transplants